On-Demand Webinars

31. Building A Path To A Successful AAV Product 1/26/2026

    See state‑of‑the‑art analytical methods for AAV characterization, key quality attributes to monitor, and approaches for measuring infectivity and full‑to‑empty capsid ratios.

32. Lyo‑Modelling For Risk Reduction And Process Insights 1/26/2026

    Use lyophilization modelling to optimize freeze‑drying, boost product quality, and lower commercialization risks through predictive insights, robustness analysis, and deeper process understanding.

33. Detecting Particles In Biologic And CGT Drug Products 1/26/2026

    Identify and characterize visible and subvisible particles that can form during biologic and cell or gene therapy development.

34. Developability Assessment And Early Formulation Studies 1/26/2026

    Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success.

35. AUC As An Alternative For Biologics, Gene Therapy Characterization 1/26/2026

    Learn how Analytical Ultracentrifugation enables detailed characterization of biologics, vaccines, and gene therapy vectors, offering a powerful alternative for R&D and emerging QC needs.

36. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

37. Mastering Ophthalmic Drug Formulation And Testing 1/15/2026

    In this on-demand webinar, our manufacturing experts provide insights into the growing ophthalmic market and how to optimize your drug development research outcomes.

38. Beyond Geographies — Derisking Global Manufacturing 1/15/2026

    Gain expert insights on mitigating risks in global pharmaceutical manufacturing by learning from Joon Chang and Tracey Partington’s decades of industry experience.

39. Sterile Filling Readiness In The Drug Device Delivery Ecosystem 1/14/2026

    Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.

40. Collaborate For Standardization In Large-Volume Subcutaneous Delivery 1/14/2026

    Establishing unified component standards through collaborative innovation eliminates unnecessary investment, reduces development timelines, and ensures scalable, patient-centered delivery systems.